Skip to main content
Top
Published in: Basic Research in Cardiology 4/2011

01-07-2011 | Original Contribution

Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis

Authors: Johanna Schneider, Achim Lother, Lutz Hein, Ralf Gilsbach

Published in: Basic Research in Cardiology | Issue 4/2011

Login to get access

Abstract

Increased activity of the sympathetic system is an important feature contributing to the pathogenesis and progression of chronic heart failure. While the mechanisms and consequences of enhanced norepinephrine release from sympathetic nerves have been intensely studied, the role of the adrenal gland in the development of cardiac hypertrophy and progression of heart failure is less well known. Thus, the aim of the present study was to determine the effect of chronic cardiac pressure overload in mice on adrenal medulla structure and function. Cardiac hypertrophy was induced in wild-type mice by transverse aortic constriction (TAC) for 8 weeks. After TAC, the degree of cardiac hypertrophy correlated significantly with adrenal weight and adrenal catecholamine storage. In the medulla, TAC caused an increase in chromaffin cell size but did not result in chromaffin cell proliferation. Ablation of chromaffin α2C-adrenoceptors did not affect adrenal weight or epinephrine synthesis. However, unilateral denervation of the adrenal gland completely prevented adrenal hypertrophy and increased catecholamine synthesis. Transcriptome analysis of microdissected adrenal medulla identified 483 up- and 231 downregulated, well-annotated genes after TAC. Among these genes, G protein-coupled receptor kinases 2 (Grk2) and 6 and phenylethanolamine N-methyltransferase (Pnmt) were significantly upregulated by TAC. In vitro, acetylcholine-induced Pnmt and Grk2 expression as well as enhanced epinephrine content was prevented by inhibition of nicotinic acetylcholine receptors and Ca2+/calmodulin-dependent signaling. Thus, activation of preganglionic sympathetic nerves innervating the adrenal medulla plays an essential role in inducing adrenal hypertrophy, enhanced catecholamine synthesis and induction of Grk2 expression after cardiac pressure overload.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96(2):526–534PubMed Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96(2):526–534PubMed
3.
go back to reference Beetz N, Harrison MD, Brede M, Zong X, Urbanski MJ, Sietmann A, Kaufling J, Barrot M, Seeliger MW, Vieira-Coelho MA, Hamet P, Gaudet D, Seda O, Tremblay J, Kotchen TA, Kaldunski M, Nusing R, Szabo B, Jacob HJ, Cowley AW Jr, Biel M, Stoll M, Lohse MJ, Broeckel U, Hein L (2009) Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest 119(12):3597–3612. doi:10.1172/JCI38433 PubMed Beetz N, Harrison MD, Brede M, Zong X, Urbanski MJ, Sietmann A, Kaufling J, Barrot M, Seeliger MW, Vieira-Coelho MA, Hamet P, Gaudet D, Seda O, Tremblay J, Kotchen TA, Kaldunski M, Nusing R, Szabo B, Jacob HJ, Cowley AW Jr, Biel M, Stoll M, Lohse MJ, Broeckel U, Hein L (2009) Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest 119(12):3597–3612. doi:10.​1172/​JCI38433 PubMed
5.
go back to reference Braunwald E, Bristow MR (2000) Congestive heart failure: fifty years of progress. Circulation 102(20 Suppl 4):IV14–IV23PubMed Braunwald E, Bristow MR (2000) Congestive heart failure: fifty years of progress. Circulation 102(20 Suppl 4):IV14–IV23PubMed
6.
go back to reference Brede M, Nagy G, Philipp M, Sorensen JB, Lohse MJ, Hein L (2003) Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol Endocrinol 17(8):1640–1646. doi:10.1210/me.2003-0035 PubMedCrossRef Brede M, Nagy G, Philipp M, Sorensen JB, Lohse MJ, Hein L (2003) Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol Endocrinol 17(8):1640–1646. doi:10.​1210/​me.​2003-0035 PubMedCrossRef
7.
go back to reference Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, Lohse MJ, Hein L (2002) Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106(19):2491–2496PubMedCrossRef Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, Lohse MJ, Hein L (2002) Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106(19):2491–2496PubMedCrossRef
8.
go back to reference Ceconi C, Curello S, Ferrari R (1998) Catecholamines: the cardiovascular and neuroendocrine system. Eur Heart J 19(Suppl F):F2–F6 Ceconi C, Curello S, Ferrari R (1998) Catecholamines: the cardiovascular and neuroendocrine system. Eur Heart J 19(Suppl F):F2–F6
9.
go back to reference CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353(9146):9–13. doi:S0140673698111819 CIBIS-II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353(9146):9–13. doi:S014067369811181​9
10.
go back to reference Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311(13):819–823PubMedCrossRef Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311(13):819–823PubMedCrossRef
11.
go back to reference Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9(13):1608–1621PubMedCrossRef Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9(13):1608–1621PubMedCrossRef
12.
go back to reference (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353(9169):2001–2007. doi:S0140673699044402 (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353(9169):2001–2007. doi:S014067369904440​2
13.
go back to reference Ehrhart-Bornstein M, Bornstein SR, Gonzalez-Hernandez J, Holst JJ, Waterman MR, Scherbaum WA (1995) Sympathoadrenal regulation of adrenocortical steroidogenesis. Endocr Res 21(1–2):13–24PubMedCrossRef Ehrhart-Bornstein M, Bornstein SR, Gonzalez-Hernandez J, Holst JJ, Waterman MR, Scherbaum WA (1995) Sympathoadrenal regulation of adrenocortical steroidogenesis. Endocr Res 21(1–2):13–24PubMedCrossRef
14.
go back to reference Evinger MJ, Ernsberger P, Regunathan S, Joh TH, Reis DJ (1994) A single transmitter regulates gene expression through two separate mechanisms: cholinergic regulation of phenylethanolamine N-methyltransferase mRNA via nicotinic and muscarinic pathways. J Neurosci 14(4):2106–2116PubMed Evinger MJ, Ernsberger P, Regunathan S, Joh TH, Reis DJ (1994) A single transmitter regulates gene expression through two separate mechanisms: cholinergic regulation of phenylethanolamine N-methyltransferase mRNA via nicotinic and muscarinic pathways. J Neurosci 14(4):2106–2116PubMed
15.
go back to reference Frey UH, Lieb W, Erdmann J, Savidou D, Heusch G, Leineweber K, Jakob H, Hense HW, Lowel H, Brockmeyer NH, Schunkert H, Siffert W (2008) Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. Eur Heart J 29(7):888–897. doi:10.1093/eurheartj/ehm618 PubMedCrossRef Frey UH, Lieb W, Erdmann J, Savidou D, Heusch G, Leineweber K, Jakob H, Hense HW, Lowel H, Brockmeyer NH, Schunkert H, Siffert W (2008) Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. Eur Heart J 29(7):888–897. doi:10.​1093/​eurheartj/​ehm618 PubMedCrossRef
16.
go back to reference Gilsbach R, Brede M, Beetz N, Moura E, Muthig V, Gerstner C, Barreto F, Neubauer S, Vieira-Coelho MA, Hein L (2007) Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res 75(4):728–737. doi:10.1016/j.cardiores.2007.05.017 PubMedCrossRef Gilsbach R, Brede M, Beetz N, Moura E, Muthig V, Gerstner C, Barreto F, Neubauer S, Vieira-Coelho MA, Hein L (2007) Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res 75(4):728–737. doi:10.​1016/​j.​cardiores.​2007.​05.​017 PubMedCrossRef
17.
go back to reference Gilsbach R, Schneider J, Lother A, Schickinger S, Leemhuis J, Hein L (2010) Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload. Cardiovasc Res 86(3):432–442. doi:10.1093/cvr/cvq014 PubMedCrossRef Gilsbach R, Schneider J, Lother A, Schickinger S, Leemhuis J, Hein L (2010) Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload. Cardiovasc Res 86(3):432–442. doi:10.​1093/​cvr/​cvq014 PubMedCrossRef
18.
go back to reference Gomez F, Lahmame A, de Kloet ER, Armario A (1996) Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 63(4):327–337PubMedCrossRef Gomez F, Lahmame A, de Kloet ER, Armario A (1996) Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 63(4):327–337PubMedCrossRef
20.
go back to reference Greenberg ME, Ziff EB, Greene LA (1986) Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science 234(4772):80–83PubMedCrossRef Greenberg ME, Ziff EB, Greene LA (1986) Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science 234(4772):80–83PubMedCrossRef
21.
22.
go back to reference Harvey PW, Sutcliffe C Adrenocortical hypertrophy: establishing cause and toxicological significance. J Appl Toxicol 30(7):617–626. doi:10.1002/jat.1569 Harvey PW, Sutcliffe C Adrenocortical hypertrophy: establishing cause and toxicological significance. J Appl Toxicol 30(7):617–626. doi:10.​1002/​jat.​1569
23.
24.
go back to reference Johnson AK, Grippo AJ (2006) Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 57(Suppl 11):5–29 Johnson AK, Grippo AJ (2006) Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 57(Suppl 11):5–29
28.
go back to reference Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ (2007) Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13(3):315–323. doi:10.1038/nm1553 PubMedCrossRef Lymperopoulos A, Rengo G, Funakoshi H, Eckhart AD, Koch WJ (2007) Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med 13(3):315–323. doi:10.​1038/​nm1553 PubMedCrossRef
29.
go back to reference Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW 2nd, Koch WJ (2010) Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem 285(21):16378–16386. doi:10.1074/jbc.M109.077859 PubMedCrossRef Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW 2nd, Koch WJ (2010) Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem 285(21):16378–16386. doi:10.​1074/​jbc.​M109.​077859 PubMedCrossRef
30.
go back to reference Nicholls DP, Onuoha GN, McDowell G, Elborn JS, Riley MS, Nugent AM, Steele IC, Shaw C, Buchanan KD (1996) Neuroendocrine changes in chronic cardiac failure. Basic Res Cardiol 91(Suppl 1):13–20 Nicholls DP, Onuoha GN, McDowell G, Elborn JS, Riley MS, Nugent AM, Steele IC, Shaw C, Buchanan KD (1996) Neuroendocrine changes in chronic cardiac failure. Basic Res Cardiol 91(Suppl 1):13–20
31.
go back to reference Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334(21):1349–1355PubMedCrossRef Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334(21):1349–1355PubMedCrossRef
32.
go back to reference Pool PE (1998) Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments? Cardiology 90(1):1–7. doi:crd90001 PubMedCrossRef Pool PE (1998) Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments? Cardiology 90(1):1–7. doi:crd90001 PubMedCrossRef
33.
go back to reference Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G, Liccardo D, Filippelli A, Ferrara N, Lisanti MP, Koch WJ, Lymperopoulos A (2010) Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am J Physiol Heart Circ Physiol 298(6):H2032–H2038. doi:10.1152/ajpheart.00702.2009 PubMedCrossRef Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G, Liccardo D, Filippelli A, Ferrara N, Lisanti MP, Koch WJ, Lymperopoulos A (2010) Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am J Physiol Heart Circ Physiol 298(6):H2032–H2038. doi:10.​1152/​ajpheart.​00702.​2009 PubMedCrossRef
35.
go back to reference Riegger AJ (1991) Role of neuroendocrine mechanisms in the pathogenesis of heart failure. Basic Res Cardiol 86(Suppl 3):125–131 Riegger AJ (1991) Role of neuroendocrine mechanisms in the pathogenesis of heart failure. Basic Res Cardiol 86(Suppl 3):125–131
38.
go back to reference Stachowiak MK, Jiang HK, Poisner AM, Tuominen RK, Hong JS (1990) Short and long term regulation of catecholamine biosynthetic enzymes by angiotensin in cultured adrenal medullary cells. Molecular mechanisms and nature of second messenger systems. J Biol Chem 265(8):4694–4702PubMed Stachowiak MK, Jiang HK, Poisner AM, Tuominen RK, Hong JS (1990) Short and long term regulation of catecholamine biosynthetic enzymes by angiotensin in cultured adrenal medullary cells. Molecular mechanisms and nature of second messenger systems. J Biol Chem 265(8):4694–4702PubMed
39.
go back to reference Takahama H, Asanuma H, Sanada S, Fujita M, Sasaki H, Wakeno M, Kim J, Asakura M, Takashima S, Minamino T, Komamura K, Sugimachi M, Kitakaze M (2010) A histamine H receptor blocker ameliorates development of heart failure in dogs independently of beta-adrenergic receptor blockade. Basic Res Cardiol 105(6):787–794. doi:10.1007/s00395-010-0119-y PubMedCrossRef Takahama H, Asanuma H, Sanada S, Fujita M, Sasaki H, Wakeno M, Kim J, Asakura M, Takashima S, Minamino T, Komamura K, Sugimachi M, Kitakaze M (2010) A histamine H receptor blocker ameliorates development of heart failure in dogs independently of beta-adrenergic receptor blockade. Basic Res Cardiol 105(6):787–794. doi:10.​1007/​s00395-010-0119-y PubMedCrossRef
42.
go back to reference Wolman M, Cervos-Navarro J, Sampaolo S, Cardesa A (1993) Pathological changes in organs of rats chronically exposed to hypoxia. Development of pulmonary lipidosis. Histol Histopathol 8(2):247–255PubMed Wolman M, Cervos-Navarro J, Sampaolo S, Cardesa A (1993) Pathological changes in organs of rats chronically exposed to hypoxia. Development of pulmonary lipidosis. Histol Histopathol 8(2):247–255PubMed
43.
go back to reference Womble JR, Larson DF, Copeland JG, Brown BR, Haddox MK, Russell DH (1980) Adrenal medulla denervation prevents stress-induced epinephrine plasma elevation and cardiac hypertrophy. Life Sci 27(24):2417–2420PubMedCrossRef Womble JR, Larson DF, Copeland JG, Brown BR, Haddox MK, Russell DH (1980) Adrenal medulla denervation prevents stress-induced epinephrine plasma elevation and cardiac hypertrophy. Life Sci 27(24):2417–2420PubMedCrossRef
44.
go back to reference Wong DL, Bildstein CL, Siddall B, Lesage A, Yoo YS (1993) Neural regulation of phenylethanolamine N-methyltransferase in vivo: transcriptional and translational changes. Brain Res Mol Brain Res 18(1–2):107–114PubMedCrossRef Wong DL, Bildstein CL, Siddall B, Lesage A, Yoo YS (1993) Neural regulation of phenylethanolamine N-methyltransferase in vivo: transcriptional and translational changes. Brain Res Mol Brain Res 18(1–2):107–114PubMedCrossRef
45.
go back to reference Wong DL, Ebert SN, Morita K (1998) Neural control of phenylethanolamine-N-methyltransferase via cholinergic activation of Egr-I. Adv Pharmacol 42:77–81PubMedCrossRef Wong DL, Ebert SN, Morita K (1998) Neural control of phenylethanolamine-N-methyltransferase via cholinergic activation of Egr-I. Adv Pharmacol 42:77–81PubMedCrossRef
Metadata
Title
Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis
Authors
Johanna Schneider
Achim Lother
Lutz Hein
Ralf Gilsbach
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Basic Research in Cardiology / Issue 4/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-011-0166-z

Other articles of this Issue 4/2011

Basic Research in Cardiology 4/2011 Go to the issue